52 In a phase 1b trial done to evaluate the safety, pharmacokinetics and pharmacodynamics of orforglipron in patients with T2DM, orforglipron resulted in significant reductions in HbA1c, fasting blood glucose and body weight, with an adverse event profile consistent with that of other GLP-1RA
It binds the GHRH receptor (GHRHR) on somatotroph cells of the anterior pituitary, activating adenylyl cyclase, raising intracellular cAMP, and triggering pulsatile growth hormone secretion
Introduction Pancreatic ductal adenocarcinoma (PDA), or pancreatic cancer, is a devastating exogenous pancreatic disease that ranks the fourth leading cause of cancer mortality and is projected to be the second leading cause of death by 2030 in the United States (Rahib et al., 2014
Fat tissue converts testosterone to estrogen through an enzyme called aromatase
This can be completed at our Miami clinic or from the comfort of home via secure telehealth
Cognitive support: as noted in the JAMA data, executive function and verbal memory improvements have been documented, making it relevant for patients with early cognitive concerns